copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home - LaboPharm A dynamic laboratory service and supply company with a collective experience spanning over 70 years For the past decade we’ve been supporting some of the biggest names across a range of industries, tapping into our team of consultants, experts, and factory-trained customer engineers
About us - LaboPharm LaboPharm’s main objective is to facilitate the interplay between your organisation and the rapidly changing and complex world of laboratory technology We’ll guide you through the entire process, from conceptualisation, through to after-sales support, with quality at every step of the way
LaboPharm - LinkedIn About us A dynamic laboratory service and supply company with a collective experience spanning over 70 years For the past decade we’ve been supporting some of the biggest names across
Labopharm Incs Oleptro - Pharmacy Times The FDA approved Labopharm's Oleptro (trazodone hydrochloride) extended-release tablets for treatment of major depressive disorder in adults
Case Studies - LaboPharm LaboPharm continues to support Actavis with extensive operators training for the proper operation of new equipment and with an ongoing maintenance agreement covering annual preventive maintenance, compliance (qualifications and calibrations) and repair services as and when they may be required
Paladin Labs on buying spree with friendly $20. 4M Labopharm deal Pharmaceutical company Paladin Labs Inc continued its buying spree Wednesday, announcing plans to acquire Labopharm Inc in a deal worth about $20 4-million The move comes just a week after its announcement of a hostile takeover bid for COLD-FX maker, Afexa Life Sciences Inc worth roughly $56 7-million
Labopharm Receives FDA Approval For OLEPTRO(TM) - PR Newswire Labopharm will conduct a post-approval pediatric study The FDA has asked Labopharm to provide data from a long-term maintenance study and an additional in-vitro alcohol dissolution study
Labopharm Inc. - Laval, Canada - bionity. com Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally